INEAS’s Cost-Effectiveness Analysis of Vemurafenib: Paving the Way for Value-Based Pricing in Tunisia

Jameleddine M, Harzallah N, Grati H, Odabachian Jebali MC, Chemli J, García Martí S, et al. INEAS’s Cost-Effectiveness Analysis of Vemurafenib: Paving the Way for Value-Based Pricing in Tunisia. J Mark Access Health Policy. 2024;12(4):294-305.